Trial NCT01264341

View at ClinicalTrials.gov 
Org. Study IDs: HE 21/10
Secondary IDs: 2010-020664-38

Last trial update was posted on 2017-02-14

MeSH Interventions

Bevacizumab MTOR Inhibitors Sirolimus Temsirolimus

MeSH Conditions

Kidney Neoplasms

Other Conditions

Kidney Cancer

Stopping Reasons

Based on the developments in the treatment of recurrent metastatic renal cancer, the study treatment is no longer considered to be the best treatment option

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID